GRCE

Grace Therapeutics
GRCE

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $112K invested in Grace Therapeutics in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

45% less capital invested

Capital invested by funds: $205K → $112K (-$92.5K)

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$22K
2
+$22K
3
+$17K
4
TWC
TD Waterhouse Canada
Ontario, Canada
+$4

Top Sellers

1
-$69K
2
-$30.7K
3
-$15K
4
Koshinski Asset Management
Koshinski Asset Management
Illinois
-$2.44K
5
UBS Group
UBS Group
Switzerland
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$22K
2
$22K
3
$17K
4
$16K
5
$16K
6
$15K
7
$4K
8
$198
9
$4
10
–
11
–
12
–
13
–
14
–